AG

Ankur Goel

Active Director Director DIN 08902202
DIN 08902202 First appointment Oct 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value •••• Premium profile

About Ankur Goel

Data last updated:

Ankur Goel is a Director at Svamrit Remedies Private Limited (since 2020). The company operates in Pharma. Svamrit Remedies Private Limited reported revenue of ₹1.3 Lakh (FY 2025).

DIN 08902202
Primary Designation Director
Industry Pharma
First Appointment 03 Oct 2020
Oldest Company Age 6 yrs
Largest company Svamrit Remedies Private Limited · ₹1.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Svamrit Remedies Private Limited U51909HR2020PTC089803
Director03 Oct 20202020₹1.3 Lakh (FY 2025)Active

Board colleagues of Ankur Goel

NameDINCompanyDesignation
Anik08902201Svamrit Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Svamrit Remedies Private Limited
Premium access

Shareholding and investment profile for Ankur Goel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankur Goel

Ankur Goel currently holds 1 directorship: Svamrit Remedies Private Limited (Director, since 03 Oct 2020, revenue ₹1.3 Lakh (FY 2025)).

Ankur Goel was first appointed on 03 Oct 2020 as Director at Svamrit Remedies Private Limited.

The current boards of Ankur Goel's companies include Anik (Svamrit Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available